Sequential BCMA/GPRC5D-targeted CAR-T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sequential BCMA/GPRC5D-targeted CAR-T cells, covering 2025-06-22 to 2025-06-22. Get the full timeline:
Most recent: Clinical Trial Update: Sequential CAR-T Cells Targeting BCMA/GPRC5D in Patients With Relapsed/ Refractory Multiple Myeloma [Phase 1, Phase 2]